• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加纳镰状细胞病患儿珠蛋白及相关基因中特定单核苷酸多态性与羟基脲治疗反应的关联

Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.

作者信息

Manu Gloria Pokuaa, Segbefia Catherine, N'guessan Benoit Banga, Coffie Shadrack Asiedu, Adjei George Obeng

机构信息

Department of Pharmacology and Toxicology, School of Pharmacy, College of Health Sciences, University of Ghana, Accra, Ghana.

Department of Child Health, University of Ghana Medical School, Accra, Ghana.

出版信息

Pharmgenomics Pers Med. 2022 Mar 10;15:205-214. doi: 10.2147/PGPM.S351599. eCollection 2022.

DOI:10.2147/PGPM.S351599
PMID:35300055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8922234/
Abstract

BACKGROUND

Sickle cell disease (SCD) is a group of genetic disorders affecting the structure and function of haemoglobin. Hydroxyurea (HU) stimulates fetal haemoglobin (HbF) and reduces sickle erythrocyte-endothelial cell interaction. However, the degree of HbF response to HU varies, with HbF expression-associated single nucleotide polymorphisms (SNPs) in quantitative trait loci (QTL) been implicated. We investigated the relationship between four SNPs (rs11886868, rs6706648, rs7606173 and 158C/T Xmn1) in two QTL (B-cell lymphoma 11A (BCL11A) and Xmn1) and HbF levels in children with SCD in Accra, Ghana.

METHODS

A total of 110 children with SCD in steady-state, comprising 64 and 46 SCD children treated with HU (HU+) or with no history of HU therapy (HU-), respectively, were recruited. HbF levels were measured in peripheral blood by alkali denaturation and SNPs were genotyped using polymerase chain reaction and restriction fragment length polymorphism.

RESULTS

The presence of SNPs (rs11886868, rs6706648, rs7606173 and -158C/T Xmn1) was identified. Observed heterozygosity and homozygosity for the derived alleles were 45.7%, 82.6%, 21.7% and 39.1% in rs11886868, rs6706648, rs7606173 and -158C/T Xmn1 polymorphisms, respectively, for the HU+ population. Observed frequencies of the minor alleles were 0.204, 0.477, 0.171 and 0.190 for rs11886868, rs6706648, rs7606173 and -158C/T Xmn1 polymorphisms, respectively. The three BCL11A SNPs in the HU+ population showed homozygous individuals for rs11886868 (CC), rs6706648 (CC) and heterozygous or homozygous mutant individuals for rs7606173 (CG/GG) having higher HbF values. The combined effect of the SNPs was associated with variance in HbF levels in the HU+ population. The BCL11A SNP, rs6706648 was strongly associated with HbF levels and the C allele frequency, with significantly elevated HbF levels.

CONCLUSION

An association between the various variants and combined effect of SNPs and HbF among children with SCD was found and confirms the known association between HU intake and increased HbF in SCD.

摘要

背景

镰状细胞病(SCD)是一组影响血红蛋白结构和功能的遗传性疾病。羟基脲(HU)可刺激胎儿血红蛋白(HbF)并减少镰状红细胞与内皮细胞的相互作用。然而,HbF对HU的反应程度各不相同,数量性状位点(QTL)中与HbF表达相关的单核苷酸多态性(SNP)被认为与之有关。我们调查了加纳阿克拉SCD儿童中两个QTL(B细胞淋巴瘤11A(BCL11A)和Xmn1)中的四个SNP(rs11886868、rs6706648、rs7606173和158C/T Xmn1)与HbF水平之间的关系。

方法

共招募了110名病情稳定的SCD儿童,其中分别有64名和46名接受HU治疗(HU+)或无HU治疗史(HU-)的SCD儿童。通过碱变性法测量外周血中的HbF水平,并使用聚合酶链反应和限制性片段长度多态性对SNP进行基因分型。

结果

鉴定出了SNP(rs11886868、rs6706648、rs7606173和-158C/T Xmn1)的存在。对于HU+人群,rs11886868、rs6706648、rs7606173和-158C/T Xmn1多态性中观察到的衍生等位基因杂合度和纯合度分别为45.7%、82.6%、21.7%和39.1%。rs11886868、rs6706648、rs7606173和-158C/T Xmn1多态性的次要等位基因观察频率分别为0.204、0.477、0.171和0.190。HU+人群中的三个BCL11A SNP显示,rs11886868(CC)、rs6706648(CC)的纯合个体以及rs7606173(CG/GG)的杂合或纯合突变个体具有较高的HbF值。SNP的联合效应与HU+人群中HbF水平的差异相关。BCL11A SNP rs6706648与HbF水平和C等位基因频率密切相关,HbF水平显著升高。

结论

发现了SCD儿童中各种变体以及SNP与HbF联合效应之间的关联,并证实了已知的HU摄入与SCD中HbF增加之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e3/8922234/a98c1f898955/PGPM-15-205-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e3/8922234/c7911f9bb758/PGPM-15-205-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e3/8922234/d5eef4f2b62f/PGPM-15-205-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e3/8922234/a98c1f898955/PGPM-15-205-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e3/8922234/c7911f9bb758/PGPM-15-205-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e3/8922234/d5eef4f2b62f/PGPM-15-205-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e3/8922234/a98c1f898955/PGPM-15-205-g0003.jpg

相似文献

1
Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease.加纳镰状细胞病患儿珠蛋白及相关基因中特定单核苷酸多态性与羟基脲治疗反应的关联
Pharmgenomics Pers Med. 2022 Mar 10;15:205-214. doi: 10.2147/PGPM.S351599. eCollection 2022.
2
Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.BCL11A、HSB1L-MYB 和 XmnI γG-158(C/T)基因多态性与埃及镰状细胞病患者血红蛋白 F 水平的关联。
Ann Hematol. 2020 Oct;99(10):2279-2288. doi: 10.1007/s00277-020-04187-z. Epub 2020 Aug 9.
3
Genotyping the Single Nucleotide Polymorphism and Associated Levels of Fetal Hemoglobin in Mauritanian Sickle Cell Patients.毛里塔尼亚镰状细胞病患者的单核苷酸多态性基因分型及胎儿血红蛋白相关水平
Front Biosci (Schol Ed). 2024 Jun 12;16(2):11. doi: 10.31083/j.fbs1602011.
4
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.BCL11A和HMIP-2基因多态性对巴西南部镰状细胞贫血患者内源性和羟基脲诱导的胎儿血红蛋白水平的作用
Blood Cells Mol Dis. 2016 Nov;62:32-37. doi: 10.1016/j.bcmd.2016.11.002. Epub 2016 Nov 9.
5
A study on the genotype frequency of -158 Gγ (C→T) 1 polymorphism in a sickle cell trait cohort from Siwa Oasis, Egypt.埃及锡瓦绿洲镰状细胞性状队列中 -158 Gγ (C→T) 1 多态性的基因型频率研究。
J Genet. 2018 Jun;97(2):505-511.
6
Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.在来自墨西哥南部的纯合子 (HbSS) 和杂合子 (HbSA) 个体中鉴定到的胎儿血红蛋白调节遗传变异。
J Trop Pediatr. 2022 Aug 4;68(5). doi: 10.1093/tropej/fmac073.
7
The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.尼日利亚镰状细胞病中胎儿血红蛋白持续存在的遗传剖析。
Hum Mol Genet. 2024 May 4;33(10):919-929. doi: 10.1093/hmg/ddae014.
8
DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.BCL11A、HBS1L-MYB和β-珠蛋白基因座的DNA多态性与镰状细胞病中的胎儿血红蛋白水平和疼痛危象相关。
Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11869-74. doi: 10.1073/pnas.0804799105. Epub 2008 Jul 30.
9
rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.BCL11A基因的rs11886868和rs4671393与胎儿血红蛋白(HbF)水平变化相关,并调节镰状细胞贫血患者的临床事件。
Hematology. 2016 Aug;21(7):425-9. doi: 10.1080/10245332.2015.1107275. Epub 2016 Jan 22.
10
Unique Polymorphisms at , and Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease.科威特镰状细胞病患者中与胎儿血红蛋白(HbF)相关的、位于、和位点的独特多态性。
J Pers Med. 2021 Jun 17;11(6):567. doi: 10.3390/jpm11060567.

引用本文的文献

1
Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approach.探索影响坦桑尼亚镰状细胞病患者羟基脲反应的药物遗传学因素:一种基因组医学方法。
Pharmacogenomics J. 2025 Apr 23;25(3):11. doi: 10.1038/s41397-025-00372-3.
2
Role of B-Cell Lymphoma/Leukemia 11A in Normal and Malignant Hematopoiesis.B细胞淋巴瘤/白血病11A在正常和恶性造血中的作用。
Biology (Basel). 2025 Jan 1;14(1):26. doi: 10.3390/biology14010026.
3
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Hydroxyurea alters hematological, biochemical and inflammatory biomarkers in Brazilian children with SCA: Investigating associations with βS haplotype and α-thalassemia.羟基脲改变了巴西 SCA 儿童的血液学、生化和炎症生物标志物:βS 单倍型和α-地中海贫血的关联研究。
PLoS One. 2019 Jul 15;14(7):e0218040. doi: 10.1371/journal.pone.0218040. eCollection 2019.
2
A study on the genotype frequency of -158 Gγ (C→T) 1 polymorphism in a sickle cell trait cohort from Siwa Oasis, Egypt.埃及锡瓦绿洲镰状细胞性状队列中 -158 Gγ (C→T) 1 多态性的基因型频率研究。
J Genet. 2018 Jun;97(2):505-511.
3
Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran.
遗传变异与镰状细胞病严重程度:系统评价和荟萃分析。
JAMA Netw Open. 2023 Oct 2;6(10):e2337484. doi: 10.1001/jamanetworkopen.2023.37484.
β-珠蛋白基因内单体型:作为伊朗北部β-地中海贫血产前诊断的新生物标志物的应用。
J Biomed Sci. 2017 Dec 4;24(1):92. doi: 10.1186/s12929-017-0396-y.
4
Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia.102名患有镰状细胞贫血的刚果患者队列中的保护性BCL11A和HBS1L-MYB基因多态性
J Clin Lab Anal. 2018 Jan;32(1). doi: 10.1002/jcla.22207. Epub 2017 Mar 23.
5
Sickle cell disease.镰状细胞病。
Lancet. 2017 Jul 15;390(10091):311-323. doi: 10.1016/S0140-6736(17)30193-9. Epub 2017 Feb 1.
6
The role of BCL11A and HMIP-2 polymorphisms on endogenous and hydroxyurea induced levels of fetal hemoglobin in sickle cell anemia patients from southern Brazil.BCL11A和HMIP-2基因多态性对巴西南部镰状细胞贫血患者内源性和羟基脲诱导的胎儿血红蛋白水平的作用
Blood Cells Mol Dis. 2016 Nov;62:32-37. doi: 10.1016/j.bcmd.2016.11.002. Epub 2016 Nov 9.
7
Evaluation of the Relationship Between Hb F Levels and Nucleated Red Blood Cells with Morbidity in Non Transfusion-Dependent Thalassemia Patients.非输血依赖型地中海贫血患者中血红蛋白F水平与有核红细胞数量和发病率之间关系的评估。
Hemoglobin. 2016 Aug;40(4):250-6. doi: 10.1080/03630269.2016.1183212. Epub 2016 May 22.
8
rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.BCL11A基因的rs11886868和rs4671393与胎儿血红蛋白(HbF)水平变化相关,并调节镰状细胞贫血患者的临床事件。
Hematology. 2016 Aug;21(7):425-9. doi: 10.1080/10245332.2015.1107275. Epub 2016 Jan 22.
9
Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.XmnI、BCL11A和HBS1L-MYB对临床表现的修饰作用:印度尼西亚β地中海贫血和血红蛋白E/β地中海贫血患者的研究
Hematol Oncol Stem Cell Ther. 2016 Jun;9(2):55-63. doi: 10.1016/j.hemonc.2016.02.003. Epub 2016 Mar 17.
10
Association between Variants at BCL11A Erythroid-Specific Enhancer and Fetal Hemoglobin Levels among Sickle Cell Disease Patients in Cameroon: Implications for Future Therapeutic Interventions.喀麦隆镰状细胞病患者中BCL11A红细胞特异性增强子变体与胎儿血红蛋白水平之间的关联:对未来治疗干预的意义。
OMICS. 2015 Oct;19(10):627-31. doi: 10.1089/omi.2015.0124. Epub 2015 Sep 22.